Rein Verbeke
postdoc
Ghent University - NM center
Gent, Belgium
Research focus is on mRNA vaccines. Happy to help with the development and characterization of mRNA-LNP vaccines or other types of nanovaccines.
About me
Dr. Rein Verbeke is a senior postdoc in the Ghent Research Group on Nanomedicines (Ghent University). His PhD focused on the design of mRNA-LNPs and the adjuvancy of mRNA vaccines. Rein continued his research on the validation of a glycolipid-adjuvanted mRNA vaccine (Galsomes) for cancer and intracellular bacterial infections. In 2022, he visited the group of Prof. Pieter Cullis, University of British Columbia, where he investigated the contribution of LNPs to the immunogenicity and reactogenicity of mRNA vaccines. Rein is also director of the Ghent Nanomedicine Center providing solutions for the formulation and in-depth characterization of bio-therapeutics in nanoparticles.
My organisation
Ghent NanoMedicine center offers cutting-edge pharmaceutical expertise and infrastructure to academic and industrial partners for the formulation of bio-therapeutics in nanoparticles from early discovery into first-in-human clinical trials, including for mRNA vaccine development.
Skills
- preclinical testing
- Analytical methods
- mRNA vaccine design
Interests
- mRNA
- LNP
- cancer vaccines
Additional questions
How would you categorise yourself?
Organisation Type
Areas of expertise
Therapeutic areas
1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.
I agreeSpeaker sessions (1)
Thursday, 17 October 2024
11:30 - 12:30
Pitch Session: Innovation pitches - Call for abstracts
Speaker presentation
Download speaker presentation